Dermata Therapeutics Inc. (NASDAQ: DRMA) is -62.98% lower on its value in year-to-date trading and has touched a low of $0.44 and a high of $3.19 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DRMA stock was last observed hovering at around $0.69 in the last trading session, with the day’s loss setting it -0.05% off its average median price target of $7.50 for the next 12 months. It is also 94.18% off the consensus price target high of $11.00 offered by 2 analysts, but current levels are 84.0% higher than the price target low of $4.00 for the same period.
Currently trading at $0.64, the stock is -3.31% and 1.10% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.23 million and changing -5.97% at the moment leaves the stock -20.81% off its SMA200. DRMA registered -72.36% loss for a year compared to 6-month loss of -14.23%.
The stock witnessed a -11.45% gain in the last 1 month and extending the period to 3 months gives it a -9.28%, and is -12.37% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.01% over the week and 10.80% over the month.
Distance from 52-week low is 48.07% and -79.81% from its 52-week high.
Dermata Therapeutics Inc. (DRMA) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Dermata Therapeutics Inc. (DRMA) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Dermata Therapeutics Inc. is expected to release its quarterly report on 03/27/2023.The EPS is expected to shrink by -223.30% this year
Dermata Therapeutics Inc. (DRMA) Top Institutional Holders
The shares outstanding are 12.10M, and float is at 8.09M with Short Float at 2.24%.
Dermata Therapeutics Inc. (DRMA) Insider Activity
A total of 12 insider transactions have happened at Dermata Therapeutics Inc. (DRMA) in the last six months, with sales accounting for 0 and purchases happening 12 times.